Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Luzi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nucleic Acids Research|November 1, 2000
HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell cultureB Bramlage, E Luzi, F Eckstein
Trends in Biotechnology|November 10, 1998
Designing ribozymes for the inhibition of gene expressionB Bramlage, E Luzi, F Eckstein
Proceedings of the National Academy of Sciences of the United States of America|September 2, 1997
The newt ribozyme is part of a riboprotein complexE Luzi, F Eckstein, G Barsacchi
European Journal of Biochemistry|July 1, 1997
Intermolecular cleavage by the newt ribozymeL Marusic, E Luzi, G Barsacchi, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|July 20, 2005
Aptamer-based biosensors for the detection of HIV-1 Tat proteinS Tombelli, M Minunni, E Luzi, et al.
La Clinica Terapeutica|September 26, 2012
[Appropriateness prescribing and doctor's professional responsibility]F Massoni, C Simeone, E Luzi, et al.
Biosensors & Bioelectronics|November 24, 2004
Development of biosensors with aptamers as bio-recognition element: the case of HIV-1 Tat proteinM Minunni, S Tombelli, A Gullotto, et al.
Cancer Gene Therapy|August 14, 2010
Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patientsE Luzi, F Marini, I Tognarini, et al.
La Clinica Terapeutica|January 5, 2017
Gambling and the need for new responses in Public Health with an addiction "sine substantia"M Crusco, F Massoni, E Luzi, et al.
La Clinica Terapeutica|November 16, 2016
Risk factors correlating event falling to eventual medico-legal responsabilityM Crusco, B Susi, E Luzi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nucleic Acids Research|November 1, 2000
HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell cultureB Bramlage, E Luzi, F Eckstein
Trends in Biotechnology|November 10, 1998
Designing ribozymes for the inhibition of gene expressionB Bramlage, E Luzi, F Eckstein
Proceedings of the National Academy of Sciences of the United States of America|September 2, 1997
The newt ribozyme is part of a riboprotein complexE Luzi, F Eckstein, G Barsacchi
European Journal of Biochemistry|July 1, 1997
Intermolecular cleavage by the newt ribozymeL Marusic, E Luzi, G Barsacchi, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|July 20, 2005
Aptamer-based biosensors for the detection of HIV-1 Tat proteinS Tombelli, M Minunni, E Luzi, et al.
La Clinica Terapeutica|September 26, 2012
[Appropriateness prescribing and doctor's professional responsibility]F Massoni, C Simeone, E Luzi, et al.
Biosensors & Bioelectronics|November 24, 2004
Development of biosensors with aptamers as bio-recognition element: the case of HIV-1 Tat proteinM Minunni, S Tombelli, A Gullotto, et al.
Cancer Gene Therapy|August 14, 2010
Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patientsE Luzi, F Marini, I Tognarini, et al.
La Clinica Terapeutica|January 5, 2017
Gambling and the need for new responses in Public Health with an addiction "sine substantia"M Crusco, F Massoni, E Luzi, et al.
La Clinica Terapeutica|November 16, 2016
Risk factors correlating event falling to eventual medico-legal responsabilityM Crusco, B Susi, E Luzi, et al.
Pageof 2